Optimizing Narcolepsy Care: Diagnosis, Treatment, and Patient Access : Episode 3

Low-Sodium Oxybate in the Treatment of Narcolepsy and Idiopathic Hypersomnia

February 25, 2025

Opinion

Video

An expert discusses the significance of low-sodium oxybate for patients with narcolepsy patients with and cardiovascular disease and compares the diagnostic criteria and clinical presentations of narcolepsy and idiopathic hypersomnia.

EP: 1.Narcolepsy Symptoms, Classification, and Causes

EP: 2.Narcolepsy Treatments

Now Viewing

EP: 3.Low-Sodium Oxybate in the Treatment of Narcolepsy and Idiopathic Hypersomnia

Video content above is prompted by the following:

What is the significance of low-sodium oxybate formulations for patients with narcolepsy who have comorbid cardiovascular disease (CVD)?
Low-sodium oxybate is also currently the only FDA-approved treatment for idiopathic hypersomnia (IH). How do the diagnostic criteria and clinical presentations of narcolepsy differ from those of IH?

Related Content

Value-Based Decision-Making in Metastatic Breast Cancer

Ian E. Krop, MD, PhD;Debra Patt, MD, PhD, MBA

September 16th 2021

Article

In this Managed Healthcare Executive® KCast, Ian Krop, M.D., Ph.D., oncologist and associate professor of medicine at Dana-Farber Cancer Institute in Boston, and Debra Patt, M.D., Ph.D., MBA, executive vice president at Texas Oncology in Austin, provide key insights into the value-based care model for patients with HER2-positive metastatic breast cancer (mBC). This article summarizes the highlights of the discussion.